Skip to main content
. Author manuscript; available in PMC: 2020 Dec 22.
Published in final edited form as: Epilepsia. 2020 Nov 30;62(1):41–50. doi: 10.1111/epi.16779

Table 3:

Variables associated with reported stable or improved seizure control vs. worsened during the COVID-19 pandemic

Variable Patients who reported no change or improved seizure control
(146)
Patients who reported worsened seizure control
(31)
p-value
Age – median (years) 48 (IQR 25) 44 (IQR 11) 0.231
Gender – female 67.1% (98) 66.7% (22) 0.840
Race / Ethnicity 40.4% Hispanic (59) 51.6% Hispanic (16) 0.542
19.9% Black/African American (29) 22.6% Black/African American (7)
11% White/Caucasian (16) 3.2% White/Caucasian (1)
1.4% Asian (2) 0% Asian (0)
13.4% Other (20) 16.3% Other (5)
13.4% Not answered (20) 6.5% Not answered (2)
Duration of epilepsy in years (median) 16 (IQR 26) 12 (IQR 9) 0.062
Epilepsy type 0.524
 Focal 78.1% (114) 87.1% (27)
 Generalized 11.6% (17) 6.5% (2)
 Unknown 10.3% (15) 6.5% (2)
Intractable Epilepsy 44.5% (65) 61.3% (19) 0.089
Number of anti-seizure medications (median) 1 (IQR 1) 2 (IQR 1) 0.178
Median average monthly seizure rate
 2019 0 (IQR 0.25, range 0 - ≥10) 0.5 (IQR 2.42, range 0 - ≥10) <0.001
 Jan & Feb 2020 0 (IQR 0, range 0 - ≥10) 0.5 (IQR 3.1, range 0 - ≥10) <0.001
 Mar, Apr, May 2020 0 (IQR 0, range 0–7.5) 2 (IQR 6, range 0 - ≥10) <0.001
Presumed COVID-19 9.6% (14) 12.9% (4) 0.829
 Reported no change in seizure
 control during acute infection
Typical seizure triggers
 Stress 26.0% (38) 54.8% (17) 0.002
 Poor sleep 10.3% (15) 22.6% (7) 0.059
 Headache / migraine 5.5% (8) 19.4% (6) 0.009
 Infection 2.1% (3) 6.5% (2) 0.180
 Missed medications 19.2% (28) 12.9% (4) 0.410
 Menstrual cycle / period 3.4% (5) 9.7% (3) 0.128
 Other 19.2% (28) 22.6% (7) 0.666
 I have no clear triggers 37.7% (55) 22.6% (7) 0.110
Believe fear of getting COVID-19 worsened seizures 5.5% (8) 61.3% (19) <0.001
Increased / worsened stress due to the COVID-19 pandemic 50% (73) 80.6% (25) 0.002
Worse sleep due to the COVID-19 pandemic 41.8% (61) 48.4% (15) 0.275
Worse epilepsy care during the COVID-19 pandemic 12.3% (18) 38.7% (12) <0.001
Difficulty obtaining anti-seizure medications 7.5% (11) 19.4% (6) 0.042
Patient canceled a Neurology appointment 20.5% (30) 9.7% (3) 0.369
Neurologist canceled an appointment 26% (38) 35.5% (11) 0.528
Completed a Neurology live video visit 21.9% (32) 25.8% (8) 0.735
 Effective way to get epilepsy care: Yes 75% (24/32) 50% (4/8) 0.243
Completed a Neurology telephone visit 60.3% (88) 58.1% (18) 0.596
 Effective way to get epilepsy care: Yes 77.3% (68/88) 66.7% (12/18) 0.626